e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.79
+0.13 (+0.51%)
Official Closing Price
Updated: 7:00 PM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
35,574,740
Open
25.76
Bid (Size)
25.78 (100)
Ask (Size)
25.80 (300)
Prev. Close
25.66
Today's Range
25.67 - 26.02
52wk Range
22.81 - 28.75
Shares Outstanding
5,606,688,356
Dividend Yield
6.67%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer Expands Pneumococcal Vaccine Push With New Programs
↗
Today 9:14 EDT
Pfizer reports Phase 2 infant vaccine data showing a stronger immune response against serotype 3 versus Prevnar 20.
Via
Benzinga
How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise
↗
Today 5:05 EDT
The next-generation version of Pfizer's $6 billion pneumococcal vaccine franchise topped its predecessor in a midstage study.
Via
Investor's Business Daily
Topics
Stocks
Performance
YTD
+2.4%
+2.4%
1 Month
-6.3%
-6.3%
3 Month
-5.8%
-5.8%
6 Month
+3.7%
+3.7%
1 Year
+9.7%
+9.7%
More News
Read More
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results
Today 5:05 EDT
From
Pfizer Inc.
Via
Business Wire
3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now
↗
May 18, 2026
Via
The Motley Fool
Topics
Intellectual Property
CK Life Sciences’ Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer
May 18, 2026
Via
MediaOutReach
Up 231%, Is RTX Proving Why It Was a Mistake for Honeywell to Replace RTX in the Dow Jones Industrial Average?
↗
May 16, 2026
Via
The Motley Fool
Topics
Economy
Stocks
BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM
↗
May 15, 2026
Via
MarketBeat
Buy, Sell, or Hold Novo Nordisk at $46?
↗
May 15, 2026
Via
The Motley Fool
My Top 3 Healthcare Stocks for May 2026
↗
May 15, 2026
Via
The Motley Fool
2 Ways to Play the Big Pharma Patent Cliff
↗
May 15, 2026
Via
MarketBeat
Topics
ETFs
Intellectual Property
1 Stock Under $50 to Target This Week and 2 We Avoid
May 15, 2026
Via
StockStory
Pfizer Just Locked In Its Next 5 Years of Growth -- Here's How
↗
May 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
↗
May 14, 2026
Via
The Motley Fool
Valneva Q1 Earnings Call Highlights
↗
May 13, 2026
Via
MarketBeat
Topics
Earnings
These Analysts Increase Their Forecasts On Arvinas After Q1 Results
↗
May 13, 2026
Via
Benzinga
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
↗
May 13, 2026
Via
The Motley Fool
3 Struggling Stocks That Could Make for Great Contrarian Buys
↗
May 13, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
May 13, 2026
From
Pfizer Inc.
Via
Business Wire
The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call
May 13, 2026
Via
StockStory
Topics
Earnings
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer
↗
May 12, 2026
Via
Benzinga
Prediction: Pfizer Will Beat the Market Over the Next 5 Years
↗
May 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Up 373%, Is ExxonMobil Proving Why It Was a Mistake for Salesforce to Replace ExxonMobil in the Dow Jones Industrial Average?
↗
May 12, 2026
Via
The Motley Fool
Topics
Stocks
Arvinas Q1 Earnings Call Highlights
↗
May 12, 2026
Via
MarketBeat
Topics
Earnings
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
Via
FinancialNewsMedia
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 25.79
When was Pfizer last traded?
The last trade of Pfizer was at 05/20/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 144.60B
How many shares of Pfizer are outstanding?
Pfizer has 145B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert